Skip to main content
All lobbying clients

TRAVERE THERAPEUTICS

Lobbying client · California · filed 2025 to 2026

Prescription pharmaceutical manufacturer of medications.

$420,000 Reported spend
6 Filings counted
1 Firms hired
7 Bills named

Spend is reported income plus in-house expenses across 6 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (102518), not by name.

 Firms hired 1
 Bills named in these filings 7
  • HR 1414
    Cameron’s Law
    6 filings
  • HR 1518
    New Era of Preventing End-Stage Kidney Disease Act
    6 filings
  • HR 946
    ORPHAN Cures Act
    6 filings
  • HR 1262
    Mikaela Naylon Give Kids a Chance Act
    3 filings
  • S 932
    Give Kids a Chance Act of 2025
    3 filings
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
    1 filing
  • HR 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
    1 filing
 Reported by year 2 years
  • 2026 $150,000 2 filings
  • 2025 $270,000 4 filings
 Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 2
  • HOUSE OF REPRESENTATIVES 6
  • SENATE 6

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem